GREY:IPHAF - Post by User
Comment by
BornReady1970on Jun 23, 2010 6:04pm
391 Views
Post# 17216034
RE: RE: RE: follow up news is not good
RE: RE: RE: follow up news is not good
.20 I think would be on the high side. At best, we will only be delayed 3-6 months. The problem, we don't have the cash to make it through a six month delay. If the FDA ask for anything that requires $$$ in the way of studies or lab time, then that is just more $$$ that we don't have and shortens the runway even more.
The last time ISA lenghtend the runway it cost 25-30% of the company, what will it cost this time? If it is anything worse than a 3-6 months delay this stock is worth nothing! Remeber that as part of lenghtening the runway we sold the IP long with the 25-30%. And the diagnotics was sold off a few months ago, so there is absolutely nothing left of salvage value if this is more than a 3-6 month delay.
I sold out after the clarification anouncement and will buy Paladin stock with the $$$. If ISA does servive then Paladin still moves with it and if it doesn't then Paladin gets the IP.
For long term ISA holders the end is near, one way or the other.